tiprankstipranks
Bright Minds Biosciences (TSE:DRUG)
CNQX:DRUG
Holding TSE:DRUG?
Track your performance easily

Bright Minds Biosciences (DRUG) Stock Price & Analysis

53 Followers

DRUG Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

41.70%2.63%55.66%
41.70% Insiders
2.63% Other Institutional Investors
55.66% Public Companies and
Individual Investors

DRUG FAQ

What was Bright Minds Biosciences’s price range in the past 12 months?
Bright Minds Biosciences lowest stock price was C$1.29 and its highest was C$108.00 in the past 12 months.
    What is Bright Minds Biosciences’s market cap?
    Currently, no data Available
    When is Bright Minds Biosciences’s upcoming earnings report date?
    Bright Minds Biosciences’s upcoming earnings report date is Mar 11, 2025 which is in 108 days.
      How were Bright Minds Biosciences’s earnings last quarter?
      Bright Minds Biosciences released its earnings results on Aug 14, 2024. The company reported C$0.052 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.052.
        Is Bright Minds Biosciences overvalued?
        According to Wall Street analysts Bright Minds Biosciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Bright Minds Biosciences pay dividends?
          Bright Minds Biosciences does not currently pay dividends.
          What is Bright Minds Biosciences’s EPS estimate?
          Bright Minds Biosciences’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Bright Minds Biosciences have?
          Bright Minds Biosciences has 6,948,489 shares outstanding.
            What happened to Bright Minds Biosciences’s price movement after its last earnings report?
            Bright Minds Biosciences reported an EPS of C$0.052 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Bright Minds Biosciences?
              Currently, no hedge funds are holding shares in TSE:DRUG
              ---

              Company Description

              Bright Minds Biosciences

              Bright Minds Biosciences Inc is a pre-clinical biosciences company. It is is focused on developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Mind Medicine
              Revive Therapeutics
              Numinus Wellness
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis